Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Clinical trial NCT01508910 · COMPLETED
Trial details
- NCT number
- NCT01508910
- Sponsor
- Lisata Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2015-11-01
- Enrollment
- 291
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.